Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OraSure’s products are widely used globally for point-of-care and at-home testing. Their rapid diagnostic tests have received regulatory approvals such as FDA clearance or CLIA waiver status. The company’s portfolio includes the first FDA-approved in-home HIV test (OraQuick® In-Home HIV Test) and a range of other commercialized infectious disease diagnostics. They also provide molecular sampling kits used in genomics research and clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OraSure Technologies.